Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35
🏠 Home   ➤    Stock news

DBV TECHNOLOGIES Stock: Shares Fall 11.11% Over the Week

DBV Technologies' stock closed at €3.20 on Friday, marking a weekly decline of 11.11%. This underperformance comes in a context where the CAC 40 limited its losses to 0.59% and the SBF 120 to 0.43% over the same period. Despite this setback, the stock maintains an impressive annual performance of 399.2%.


DBV TECHNOLOGIES Stock: Shares Fall 11.11% Over the Week

Weekly Stock Performance

Over the past week, DBV Technologies' stock price followed a downward trajectory, closing at €3.20 on Friday after a session up by 2.24%. This negative weekly change of 11.11% contrasts with the robustness shown over the year, where the stock has increased by 399.2%, driven by a sustained upward momentum since the beginning of 2025. Trading was particularly lively, with notable volumes observed towards the end of the week. On December 23, the price dropped by 8.61% to €3.13, while December 22 recorded a decrease of 4.86% to €3.425. This weekly volatility, with a monthly volatility of 34.52%, highlights an increased sensitivity to market movements. For comparison, the CAC 40 only fell by 0.59% and the SBF 120 by 0.43% over the same period, indicating that DBV Technologies underperformed the major French indices. The beta of 0.36 measures a lower correlation with the overall market, which did not prevent a more marked decline this week. The support threshold is at €2.26 and resistance at €3.68, thus framing recent fluctuations. This weekly development opposes the positive monthly trend of over 40%, but highlights a rotation of capital with volumes increasing during bearish sessions. The high float at nearly 99% facilitates these movements, while the market capitalization hovers around 500 million euros according to recent sources. Overall, this week of correction comes after a series of previous increases, such as +108% over three months and +113% over six months, confirming the strong annual momentum despite the brief setback.

Institutional Movements

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

The Caisse des dépôts et consignations (CDC) crossed below the 5% threshold of capital and voting rights of DBV Technologies on December 17, according to a declaration to the AMF. This move below 5% reflects an adjustment in the public institution's holdings, occurring during a week of declining stock prices for the company. Daily trading shows a continuation of selling pressure: after stability at €3.68 on December 18, the price declined by 2.17% on December 19 to €3.60, before more pronounced drops towards the end of the week. This institutional context coincides with the weekly close at €3.20, in a Christmas market characterized by variable but sustained volumes.

Technical Analysis

From a technical standpoint, the stock is trading above its 50-day moving average at €2.70 and well above the 200-day moving average at €1.90, indicating a bullish medium-term position. The RSI at 66 reflects a neutral to positive dynamic, without imminent overbuying. The MACD line at 0.24 confirms a bullish signal, while the Bollinger Bands stretch from €1.91 at the bottom to €3.96 at the top, enveloping the current price in a zone of moderate volatility. The resistance threshold at €3.68 remains close, while the support at €2.26 provides a distant floor.



Sector Santé · Biotechnologies · Pharmacie Biotechnologie


Assurance vie

Context

Period
  • Period: 3T 2025
Guidance from the release
  • Perte nette trimestrielle de (33,2) millions de dollars ; trésorerie de 69,8 millions de dollars au 30/09/2025 suite à un financement partiel (125,5 M$ reçu) et un programme ATM ; dépenses opérationnelles élevées principalement en R&D (83,8 M$ sur 9 mois). Trésorerie estimée suffisante jusqu'au T3 2026 mais incertitude significative persiste.
Risks mentioned
  • Incertitude significative sur la continuité d'exploitation (trésorerie insuffisante pour couvrir 12 prochains mois)
  • Dépendance aux financements externes (PIPE, ATM et autres levées de fonds)
  • Accès futur aux capitaux soumis aux conditions du marché et à l'intérêt des investisseurs
  • Dépendance aux résultats de l'étude de phase 3 VITESSE pour accélération d'exercices de BSA et financements supplémentaires
Opportunities identified
  • Financement pouvant atteindre 306,9 millions de dollars via PIPE
  • Programme ATM pouvant générer jusqu'à 150,0 millions de dollars
  • Potentiel réglementaire et commercial du patch Viaskin® Peanut (BLA et lancement aux États-Unis si approuvé)
  • Possibilité d'exercices supplémentaires de bons de souscription si certains critères sont atteints

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit